| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 71.09M | 68.09M | 97.17M | 130.49M | 106.90M |
| Gross Profit | 30.60M | 19.29M | 46.49M | 42.25M | 44.12M |
| EBITDA | -6.09M | -2.10M | 35.25M | 18.17M | 50.21M |
| Net Income | -15.22M | -16.22M | -2.21M | -16.64M | -34.97M |
Balance Sheet | |||||
| Total Assets | 336.99M | 350.81M | 432.28M | 618.52M | 649.42M |
| Cash, Cash Equivalents and Short-Term Investments | 22.32M | 34.44M | 72.91M | 49.74M | 19.66M |
| Total Debt | 95.99M | 107.22M | 135.88M | 369.91M | 352.77M |
| Total Liabilities | 188.06M | 237.52M | 282.70M | 442.25M | 410.33M |
| Stockholders Equity | -114.07M | -38.88M | -12.42M | 3.53M | 11.15M |
Cash Flow | |||||
| Free Cash Flow | -5.44M | -9.59M | 30.68M | 45.72M | 16.44M |
| Operating Cash Flow | -5.34M | -9.46M | 30.81M | 46.52M | 16.49M |
| Investing Cash Flow | 1.10M | 9.56M | 9.30M | 5.66M | 135.06M |
| Financing Cash Flow | -7.54M | -36.83M | -23.02M | -22.77M | -176.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$276.00M | 7.57 | 13.15% | ― | 15.66% | -1.25% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
54 Neutral | HK$338.02M | 13.36 | 7.35% | 1.30% | -4.14% | -21.15% | |
47 Neutral | HK$68.54M | -1.39 | ― | ― | 3.35% | 17.48% | |
45 Neutral | HK$512.19M | -14.99 | -23.19% | ― | -18.68% | -3305.88% | |
41 Neutral | HK$131.93M | -39.56 | -7.08% | ― | -32.89% | 57.23% | |
40 Underperform | HK$101.02M | 458.76 | -65.18% | ― | ― | ― |